For a young mother with cancer, coping with the disease includes refusing to call the disease by its name. (ASCO Connection)
The FDA has granted breakthrough therapy designation for use of daratumumab (Darzalex) in combination with two different standard regimens as second-line therapy for multiple myeloma.
The American Cancer Society has invited applications from the general public to participate in the organization's peer review process for awarding cancer research grants.
To deal with ongoing drug shortages (including some cancer drugs), the FDA periodically has relaxed or lifted bans on importation of products from foreign processing plants that have questionable safety records. (FiercePharma)
Routine removal of fallopian tubes -- the suspected origin of most ovarian cancers -- during hysterectomy did not adversely affect surgical outcomes, according to a Kaiser Permanente study. (Science Daily, Obstetrics & Gynecology)
Low tumor expression of vitamin D receptor may identify more aggressive forms of breast cancer. (Roswell Park Cancer Institute, Clinical Cancer Research)
A prostate cancer survivor struggles to "get back in the game" while dealing with postoperative erectile dysfunction. (ASCO Connection)
A liquid biopsy technique has shown promise for early detection of recurrent ovarian cancer. (Science Daily, SGO Women's Cancer News).
Chinese cancer researchers will soon begin the first-ever clinical trial of genetically modified cells to treat patients with lung cancer. (Nature)
The accuracy of breast cancer gene profile tests may vary substantially according to area of the tumor selected for obtaining a tissue sample. (University of Pittsburgh Cancer Institute, Clinical Cancer Research)
Caucasians have the highest incidence of melanoma but nonwhites have a greater risk of dying of the disease, particularly African Americans. (American Academy of Dermatology)
OncoBreak: Coping With 'Candyce'; Drug Shortages vs Safety; Gene Profile Accuracy
Aucun commentaire:
Enregistrer un commentaire